NEW YORK (GenomeWeb News) – The UK's Academy of Medical Sciences is calling for greater investment into genome-wide association studies and has offered several recommendations for ways to ensure that GWAS findings will ultimately benefit patients.

In a report released yesterday, AMS noted that "despite the many successes and exciting potential of GWA studies, there is considerable scope to further capitalize on the opportunities and secure real benefits for healthcare," though it adds that "fulfilling this promise will take time."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.